The impact of the treatment of benign prostatic hyperplasia with lower urinary tract symptoms on quality of life, a scoping literature review aided by AI

被引：0

作者：

Faraon, Bjarne ^{[1
,2
]}

Garces, Juan ^{[1
]}

Ahmad, Sulaiman ^{[1
]}

Mahmoud, Satanay ^{[1
]}

Danzinger, Marc ^{[1
,2
]}

Shabsigh, Ridwan ^{[1
,2
,3
]}

Mikelinich, Erik ^{[4
]}

Carpo, Bea ^{[4
]}

机构：

[1] SBH Hlth Syst, Dept Surg, Bronx, NY 10457 USA

[2] CUNY, Sch Med, New York, NY 10031 USA

[3] Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA

[4] NYIT Coll Osteopath Med, Glen Head, NY 11545 USA

来源：

JOURNAL OF MENS HEALTH | 2024年 / 20卷 / 07期

关键词：

Benign prostatic hyperplasia; Lower urinary tract symptoms; Quality of life; Intervention; TRANSURETHRAL RESECTION; PROSPECTIVE CROSSOVER; MANAGEMENT; EFFICACY; THERAPY; LASER; MEN;

D O I：

10.22514/jomh.2024.104

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Benign prostatic hyperplasia (BPH) refers to a non-cancerous condition characterized by hyperplastic changes in stromal and epithelial cells. BPH can cause lower urinary tract symptoms (LUTS) that decrease quality of life (QoL). The International Prostate Symptom Score (IPSS) is a validated tool used to assess and guide the management of LUTS. This scoping review evaluated the difference in IPSS and QoL in patients with BPH and LUTS before and after medical or interventional treatment. A PubMed search was conducted using: (Benign prostatic hyperplasia OR lower urinary tract symptoms) AND (erectile dysfunction OR depression OR disability-adjusted life year OR quality of life), which yielded 7143 results over 10 years. With the use of artificial intelligence (AI), 31 articles were included in the study. Randomized control trials, prospective clinical trials, prospective and retrospective cohort studies, and meta-analyses were included. IPSS and IPSS-QoL measurements before and after intervention were required. Data was assessed in three categories "overall", "medical" and "interventional". Mean age, IPSS and QoL scores before and after intervention were calculated, as well as the Pearson correlation between baseline IPSS and QoL. Thirteen articles were categorized as medical while 18 were categorized as interventional. Pearson correlation between IPSS and QoL for overall, medical and interventional articles were r = 0.72, 0.79 and 0.36, respectively. There was an improvement in the QoL score by 1.28 points, 1.40 points, 2.49 points for overall, medical, and interventional groups, respectively. This study quantified the improvement in QoL after medical and interventional treatment of BPH. There is a strong correlation between the severity of BPH symptoms and the reduction of QoL. Improvement of BPH symptoms with medical and surgical treatments is associated with significant improvement in QoL.

引用

页码：8 / 14

页数：7

共 50 条

[31] The impact of treatment on lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) progression
Berges, R
EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 12 - 17
[32] Lower urinary tract - A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same?
Irani, J
Brown, CT
van der Meulen, J
Emberton, M
BJU INTERNATIONAL, 2003, 92 (09) : 937 - 942
[33] Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence
Carrero-Lopez, V. M.
Cozar-Olmo, J. M.
Minana-Lopez, B.
ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (05): : 288 - 294
[34] Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia: A Cochrane review summary
Long, JoAnn D.
Smith, Stephan R.
INTERNATIONAL JOURNAL OF NURSING STUDIES, 2021, 115
[35] Toward better treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia?
Ventura, Sabatino
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 315 (01) : F138 - F139
[36] Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia
Alberto A Antunes
Miguel Srougi
Rafael F Coelho
Geraldo de Campos Freire
Nature Clinical Practice Urology, 2007, 4 : 155 - 160
[37] Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function
Lowe, FC
BJU INTERNATIONAL, 2005, 95 : 12 - 18
[38] Editorial comment: Treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
Tammela, Teuvo L. J.
SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 (02) : 90 - 91
[39] Saw Palmetto for the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Hammer, Noa C.
Thiede, Jilt
AMERICAN FAMILY PHYSICIAN, 2024, 109 (05) : 396 - 397
[40] Lower urinary tract symptoms/benign prostatic hyperplasia: Minimizing morbidity caused by treatment
Schulman, CC
UROLOGY, 2003, 62 (3A) : 24 - 33

← 1 2 3 4 5 →